Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
- 23 September 2005
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 207 (1) , 242-260
- https://doi.org/10.1111/j.0105-2896.2005.00306.x
Abstract
In antigen-presenting cells (APCs), loading of major histocompatibility complex class II (MHC II) molecules with peptides is regulated by invariant chain (Ii), which blocks MHC II antigen-binding sites in pre-endosomal compartments. Several molecules then act upon MHC II molecules in endosomes to facilitate peptide loading: Ii-degrading proteases, the peptide exchange factor, human leukocyte antigen-DM (HLA-DM), and its modulator, HLA-DO (DO). Here, we review our findings arguing that DM stabilizes a globally altered conformation of the antigen-binding groove by binding to a lateral surface of the MHC II molecule. Our data imply changes in the interactions between specificity pockets and peptide side chains, complementing data from others that suggest DM affects hydrogen bonds. Selective weakening of peptide/MHC interactions allows DM to alter the peptide repertoire. We also review our studies in cells that highlight the ability of several factors to modulate surface expression of MHC II molecules via post-Golgi mechanisms; these factors include MHC class II-associated Ii peptides (CLIP), DM, and microbial products that modulate MHC II traffic from endosomes to the plasma membrane. In this context, we discuss possible mechanisms by which the association of some MHC II alleles with autoimmune diseases may be linked to their low CLIP affinity.Keywords
This publication has 146 references indexed in Scilit:
- Membrane specializations and endosome maturation in dendritic cells and B cellsTrends in Cell Biology, 2004
- The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic ProteinsJournal of Virology, 2003
- Regulated Expression of Human Histocompatibility Leukocyte Antigen (HLA)-DO During Antigen-dependent and Antigen-independent Phases of B Cell DevelopmentThe Journal of Experimental Medicine, 2002
- Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexesEuropean Journal of Immunology, 2002
- A Three-Step Kinetic Mechanism for Peptide Binding to MHC Class II ProteinsBiochemistry, 2000
- A New Look at MHC and Autoimmune DiseaseScience, 1999
- Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DMEuropean Journal of Immunology, 1999
- Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface.The Journal of cell biology, 1996
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- MHC class II-associated invariant chain contains a sorting signal for endosomal compartmentsCell, 1990